Fig 1. Markov State-transition decision model for Hepatitis C and liver disease: The model consists of two phases: treatment and natural history.
If patients discontinue treatment due to adverse events or fail to respond and hence not achieve SVR, they enter the natural history component of the model, consisting of 15 health states: Fibrosis states (F0–F4); decompensated cirrhosis first (DC1) and subsequent years (DC2); hepatocellular carcinoma first (HCC1) and subsequent years (HCC2); liver transplant first (LT1) and subsequent years (LT2); disease specific mortality; mortality from all other causes (not shown); and SVR status states stratified by fibrosis stage (“SVR F0-F2”, “SVR-F3”, SVR-F4). For clarity, only liver transplant is stratified by state year. This figure is similar but not identical to the original image, and is therefore for illustrative purposes only.